NCT00251823View on ClinicalTrials.gov

Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI)

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

September 30, 2008

Conditions
Myocardial Infarction
Interventions
DRUG

Eptifibatide facilitated PCI

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

Sponsors

Collaborators (2)

Schering-Plough
Medtronic
All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

collaborator

Medtronic

INDUSTRY

lead

Ottawa Heart Institute Research Corporation

OTHER